🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sminu Bose

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-2911-9991

Also affiliated with Cornell University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Multi-modal single-cell profiling of sarcomas from archival tissue reveals mechanisms of resistance to immune checkpoint inhibitors.”.

Multi-modal single-cell profiling of sarcomas from archival tissue reveals mechanisms of resistance to immune checkpoint inhibitors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e23518

N/A

0DataRank · unranked

0 citations

Sminu Bose, Amit Dipak Amin, Somnath Tagore, Johannes C. Melms, Simon Berhe +4 more

Therapeutic advances in leiomyosarcoma

Frontiers in Oncology(2023)10.3389/fonc.2023.1149106

N/A

0DataRank · unranked

49 citations

Sminu Bose, Matthew Ingham, Gary K. Schwartz, Kristine Peregrino Lacuna

ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11531

N/A

0DataRank · unranked

1 citations

Shing M. Lee, Liner Ge, Mihaela Druta, Anthony P. Conley, Mary Louise Keohan +14 more